Johanna A. Knipper, Sharon M. Campbell, Judith E. Allen, Matthew D. Taylor
{"title":"PD-L2 Inhibits Protective Immunity, Th2 Cell Functional Quality, and GATA-3 Expression During Filarial Nematode Infection","authors":"Johanna A. Knipper, Sharon M. Campbell, Judith E. Allen, Matthew D. Taylor","doi":"10.1002/eji.70021","DOIUrl":null,"url":null,"abstract":"<p>Filarial nematodes infect over 200 million people, predominantly stimulating a Type 2 immune response. Protective immunity takes decades to become effective due to dominant immune suppression that develops during infection. Using <i>Litomosoides sigmodontis</i> infection as a murine model of filariasis, we previously demonstrated that PD-1 co-inhibition causes Th2 cells to become intrinsically dysfunctional or hypo-responsive during infection, resulting in impaired protective immunity. Τhis study demonstrates that Th2 cell-intrinsic hypo-responsiveness is associated with a loss of GATA-3 expression by CD4<sup>+</sup> T cells from WT, but not PD-L2<sup>−/−</sup> mice. PD-L2<sup>−/−</sup> mice were more resistant to <i>L. sigmodontis</i> and had increased Th2 cell-intrinsic functional quality. CD19<sup>+</sup> B cells expressed PD-L2, and Jh<sup>−/−</sup> B cell-deficient mice were more resistant to infection. However, Th2 cell-intrinsic hypo-responsiveness still developed in Jh<sup>−/−</sup> mice, and restricting PD-L2 deficiency to B cells using bone marrow chimaeras did not alter resistance to <i>L. sigmodontis</i> or Th2 cell-intrinsic functional quality. Together, these data indicate that PD-L2 inhibits protective immunity to <i>L. sigmodontis</i>, downregulates GATA-3 in CD4<sup>+</sup> T cells, and induces Th2 cell-intrinsic hypo-responsiveness. Whilst B cells play a suppressive role during infection, this is independent of PD-L2 and B cells do not instigate Th2 cell-intrinsic hypo-responsiveness.</p>","PeriodicalId":165,"journal":{"name":"European Journal of Immunology","volume":"55 8","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/eji.70021","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Immunology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/eji.70021","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Filarial nematodes infect over 200 million people, predominantly stimulating a Type 2 immune response. Protective immunity takes decades to become effective due to dominant immune suppression that develops during infection. Using Litomosoides sigmodontis infection as a murine model of filariasis, we previously demonstrated that PD-1 co-inhibition causes Th2 cells to become intrinsically dysfunctional or hypo-responsive during infection, resulting in impaired protective immunity. Τhis study demonstrates that Th2 cell-intrinsic hypo-responsiveness is associated with a loss of GATA-3 expression by CD4+ T cells from WT, but not PD-L2−/− mice. PD-L2−/− mice were more resistant to L. sigmodontis and had increased Th2 cell-intrinsic functional quality. CD19+ B cells expressed PD-L2, and Jh−/− B cell-deficient mice were more resistant to infection. However, Th2 cell-intrinsic hypo-responsiveness still developed in Jh−/− mice, and restricting PD-L2 deficiency to B cells using bone marrow chimaeras did not alter resistance to L. sigmodontis or Th2 cell-intrinsic functional quality. Together, these data indicate that PD-L2 inhibits protective immunity to L. sigmodontis, downregulates GATA-3 in CD4+ T cells, and induces Th2 cell-intrinsic hypo-responsiveness. Whilst B cells play a suppressive role during infection, this is independent of PD-L2 and B cells do not instigate Th2 cell-intrinsic hypo-responsiveness.
期刊介绍:
The European Journal of Immunology (EJI) is an official journal of EFIS. Established in 1971, EJI continues to serve the needs of the global immunology community covering basic, translational and clinical research, ranging from adaptive and innate immunity through to vaccines and immunotherapy, cancer, autoimmunity, allergy and more. Mechanistic insights and thought-provoking immunological findings are of interest, as are studies using the latest omics technologies. We offer fast track review for competitive situations, including recently scooped papers, format free submission, transparent and fair peer review and more as detailed in our policies.